510k semaglutide immunoassay Novo Nordisk Submits CagriSema for FDA Approval for Obesity Treatment Obesity, Diabetes and Metabolic Disease
Pay in 4 interest-free payments of $6.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


























